Federal Register Notice: FDA is announcing an opportunity for public comment on the information collection requirements relating to FDA's adverse experience reporting (AER) for licensed biological products, and general records associated with the manufacture and distribution of biological products. Comments should be submitted by 1/3/05. To view this notice, click here.
